Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.3c01360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Chunlei Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Key Laboratory for Bio-Manufacturing, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 2501…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Qilu University of Technology, Taishan Scholar Project of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) offer an opportunity to overcome multidrug resistance. Here, novel peptides were designed based on AMP fragments derived from sea cucumber hemolytic lectin to enhance anti-methicillin-resistant Staphylococcus aureus (MRSA) activity with less side effects. Two designed peptides, CGS19 (LARVARRVIRFIRRAW-NH2) and CGS20 (RRRLARRLIFFIRRAW-NH2), exhibited strong antibacterial activities against clinically isolated MRSA with MICs of 3-6 μM, but no obvious cytotoxicity was observed. Consistently, CGS19 and CGS20 exerted rapid bactericidal activity and effectively induced 5.9 and 5.8 log reduction of MRSA counts in mouse subeschar, respectively. Further, CGS19 and CGS20 kill bacteria not only through disturbing membrane integrity but also by binding formate-tetrahydrofolate ligase, a key enzyme in the folate metabolism pathway, thereby inhibiting the folate pathway of MRSA. CGS19 and CGS20 are promising lead candidates for drug development against MRSA infection. The dual mechanisms on the identical peptide sequence or scaffold might be an underappreciated manner of treating life-threatening pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shandong Provincial Key Laboratory for Bio-Manufacturing, Biology Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250103, China.
- Department of Pharmacy, Qilu Hospital, Cheloo College of Medicine, Shandong University, Jinan 250012, China.
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu 610041, China.
- State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.
ORCID-Profile: Chunlei Li, Shenlin Wang
Förderung
- Qilu University of Technology
- Taishan Scholar Project of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Key Technology Research and Development Program of Shandong Province
- Exploration Innovation Team
- Jinan Talent Project for Universities
Zitieren
APA
Li, C., Zhou, Z., Wang, W., Zhao, Y., Yin, X., Meng, Y., Zhao, P., Wang, M., Liu, X., Wang, X., Wang, S., Ren, B., Zhang, L., & Xia, X. (2024). Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01360
Vancouver
Li C, Zhou Z, Wang W, Zhao Y, Yin X, Meng Y, et al. Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c01360
BibTeX
@article{Li2024,
author = {Li, Chunlei and Zhou, Ziyi and Wang, Weitao and Zhao, Yanqiu and Yin, Xin and Meng, Yiwei and Zhao, Peipei and Wang, Mengmeng and Liu, Xueting and Wang, Xinye and Wang, Shenlin and Ren, Biao and Zhang, Lixin and Xia, Xuekui},
title = {Development of Antibacterial Peptides with Membrane Disruption and Folate Pathway Inhibitory Activities against Methicillin-Resistant Staphylococcus aureus},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.3c01360}
}
EUVIMED